Ron McElmurry

Researcher 5
Scientist, Department of Pediatrics

Ron McElmurry

Contact Info

Researcher 5
Scientist
, Department of Pediatrics


Summary

Research interests: recessive dystrophic epidermolysis bullosa, cancer, bone marrow transplant, natural killer cells

Research

Research Summary/Interests

Recessive dystrophic epidermolysis bullosa, cancer, bone marrow transplant, natural killer cells

Publications

1.Vanden Oever M, Muldoon D, Mathews W, McElmurry R, Tolar J.miR-29 Regulates Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa. J Invest Dermatol. 2016 Oct;136(10):2013-21. doi: 10.1016/j.jid.2016.05.115. PMID:2732830

2.Osborn MJ, Webber BR, McElmurry RT, Rudser KD, DeFeo AP, Muradian M, Petryk A, Hallgrimsson B, Blazar BR, Tolar J, Braunlin EA. Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology. J Inherit Metab Dis. 2016 Oct 14. [Epub ahead of print]

3.Modiano JF, Lindborg BA, McElmurry RT, Lewellen M, Forster CL, Zamora EA, Schaack J, Bellgrau D, O'Brien TD, Tolar J.Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment. Cancer Immunol Immunother.2015 Nov;64(11):1449-60. http://dx.doi.org/10.1007/s00262-015-1749-6. PMID: 26250807. PMCID: PMC4618101.

4.Vallera DA, Felices M, McElmurry RT, McCullar V, Zhou X, Schmohl J, Zhang B, Lenvik A, Panoskaltsis-Mortari A, Verneris MR, Tolar J, Cooley S, Weisdorf D, Blazar BR, Miller JS.IL-15 Trispecific Killer Engagers (TriKEs) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing In Vivo Expansion, and Enhanced Function.Clin Cancer Res. 2016 Feb 4. pii: clincanres.2710.2015.

5.Vallera DA, Felices M, McElmurry R, McCullar V, Zhou X, Schmohl JU, Zhang B, Lenvik AJ, Panoskaltsis-Mortari A, Verneris MR, Tolar J, Cooley S, Weisdorf DJ, Blazar BR, Miller JS.IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function.Clin Cancer Res. 2016 Jul 15;22(14):3440-50. doi: 10.1158/1078-0432.CCR-15-2710.PMID:26847056